Stockscreener 앱 받기
0.92
3.35%
0.0298
시간 외 거래:
.94
0.02
+2.17%
Marker Therapeutics Inc 주식(MRKR)의 최신 뉴스
Cerenome (Nasdaq:CNSY)Análisis de acciones - Simply Wall Street
Marker Therapeutics, Inc. Highlights Expanded Manufacturing Capabilities Supporting Mt-601 - marketscreener.com
Electra Therapeutics (ETRA) pursues IPO as auditor raises going-concern warning - Stock Titan
CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight - Business Upturn
CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight - The Manila Times
Marker Therapeutics (MRKR) Holds at $1.24 as Shares Trade Flat Within RangeIV Rank - dars.gov.et
Marker Therapeutics (MRKR) Holds at $1.24 as Shares Trade Flat Within RangeVolume Spike Alerts - siam.in
Marker Therapeutics (MRKR) Holds at $1.24 as Shares Trade Flat Within RangeUndervalued Stocks - dars.gov.et
Marker Therapeutics Inc. (MRKR) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Is Marker Therapeutics (NASDAQ:MRKR) In A Good Position To Deliver On Growth Plans? - webull.com
Is Marker Therapeutics (NASDAQ:MRKR) In A Good Position To Deliver On Growth Plans? - Simply Wall Street
H.C. Wainwright reiterates Marker Therapeutics stock rating at buy By Investing.com - Investing.com India
H.C. Wainwright reiterates Marker Therapeutics stock rating at buy By Investing.com - Investing.com Canada
H.C. Wainwright reiterates Marker Therapeutics stock rating at buy By Investing.com - Investing.com UK
H.C. Wainwright reiterates Marker Therapeutics stock rating at buy - Investing.com
US High Growth Tech Stocks To Watch In August 2026 - simplywall.st
US High Growth Tech Stocks To Watch In August 2026 - simplywall.st
Marker Therapeutics (MRKR) Rises 1.75%, Holding Above Key $1.10 SupportIchimoku Kumo Twist - vinanet.vn
Marker Therapeutics (MRKR) Rises 1.75%, Holding Above Key $1.10 SupportHidden Order - careplusvn.com
Marker Therapeutics (MRKR) Rises 1.75%, Holding Above Key $1.10 SupportPrice Target - dars.gov.et
Marker Therapeutics (MRKR) Rises 1.75%, Holding Above Key $1.10 SupportRTH Profile - dars.gov.et
Marker Therapeutics Stock Price Forecast. Should You Buy MRKR? - StockInvest.us
Marker Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
MRKR Advances 2.7% to $1.14 as Biotech Stock Holds Above Key SupportVanna Flow - vinanet.vn
Marker Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
MRKR Advances 2.7% to $1.14 as Biotech Stock Holds Above Key SupportSmart Money Flow Stocks - careplusvn.com
CCORF Maintains Marker Therapeutics(MRKR.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Stock List: Research Stocks from Around the World - GuruFocus
Marker Therapeutics Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
Marker Therapeutics Inc (MRKR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MRKR Q1 2026 Earnings: Narrower-Than-Expected Loss of $0.16 Per Share Marks 14.44% EPS SurpriseAnnual Financial Report - careplusvn.com
MRKR Q1 2026 Earnings: Narrower-Than-Expected Loss of $0.16 Per Share Marks 14.44% EPS SurpriseProfit Inflection Point - vinanet.vn
MRKR Q1 2026 Earnings: Narrower-Than-Expected Loss of $0.16 Per Share Marks 14.44% EPS SurprisePeak Earnings Alert - dars.gov.et
MRKR Q1 2026 Earnings: Narrower-Than-Expected Loss of $0.16 Per Share Marks 14.44% EPS SurpriseBasic EPS Analysis - dars.gov.et
Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates - Intellia Therapeutics
Cerenome (Nasdaq:CNSY)Aktienanalyse - Simply Wall Street
MRKR Q1 2026 Earnings: Narrower Loss Beats Estimates as Investors Focus on Clinical MilestonesGuidance Downgrade Alert - vinanet.vn
Marker Therapeutics, Inc. Revenue Breakdown – NASDAQ:MRKR - TradingView
Marker Therapeutics Inc (MRKR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Marker Therapeutics Inc (MRKR) Balance Sheet - TradingKey
Marker Therapeutics Inc (MRKR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Marker Therapeutics Inc (MRKR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Marker Therapeutics Inc (MRKR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
MRKR|Marker Therapeutics Inc|Price:1.200|Chg%:-0.020 - TradingKey
MRKR|Marker Therapeutics Inc|Price:1.220|Chg%:-0.050 - TradingKey
MRKR|Marker Therapeutics Inc|Price:1.200|Chg%:-0.020 - TradingKey
Marker Therapeutics Inc (MRKR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
US High Growth Tech Stocks to Watch for Potential Expansion - simplywall.st
1.35%
자본화:
|
볼륨(24시간):